Comment from Ashland LLC

Summary: Ashland, a global specialty chemicals company, supports the draft guidance on New Approach Methodologies (NAMs) to reduce reliance on animal testing. They specifically recommend that the guidance be expanded to include pharmaceutical excipients to support the development of novel, human-relevant safety data.